Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$348000.0.

  • Harvard Bioscience's Cash from Investing Activities rose 6867.69% to -$348000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year increase of 1077.88%. This contributed to the annual value of -$1.3 million for FY2024, which is 2529.18% up from last year.
  • According to the latest figures from Q3 2025, Harvard Bioscience's Cash from Investing Activities is -$348000.0, which was up 6867.69% from -$233000.0 recorded in Q2 2025.
  • Over the past 5 years, Harvard Bioscience's Cash from Investing Activities peaked at $458000.0 during Q2 2024, and registered a low of -$1.1 million during Q3 2024.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$401000.0 (2023), whereas its average is -$386421.1.
  • In the last 5 years, Harvard Bioscience's Cash from Investing Activities tumbled by 35148.94% in 2023 and then surged by 17328.0% in 2024.
  • Quarter analysis of 5 years shows Harvard Bioscience's Cash from Investing Activities stood at -$358000.0 in 2021, then soared by 34.36% to -$235000.0 in 2022, then plummeted by 351.49% to -$1.1 million in 2023, then surged by 56.08% to -$466000.0 in 2024, then increased by 25.32% to -$348000.0 in 2025.
  • Its last three reported values are -$348000.0 in Q3 2025, -$233000.0 for Q2 2025, and -$683000.0 during Q1 2025.